Cited by 3Prenatal Screening and DiagnosticsIon Transport and Channel RegulationPregnancy and preeclampsia studies

Diagnosis of antenatal Bartter syndrome

Open access
Narayan, R., Peres, M., Kesby, G.·2016·Clinical and Experimental Obstetrics & Gynecology

Abstract

ESTABLISHED FACTS: Bartter syndrome is a rare heterogeneous group of autosomal-recessive salt-losing renal tubular disorders that can present in fetal life (antenatal Bartter syndrome; ABS) as "unexplained" early-onset polyhydramnios, often associated with growth restriction. Prenatal diagnosis of the condition involves assessment of amniotic fluid biochemistry in a setting of polyuric polyhydramnios; with elevated chloride levels considered a consistent and diagnostic finding. Other amniotic fluid biochemical markers have been described, notably increased aldosterone levels, and low total protein levels. NOVEL INSIGHT: Antenatal Bartter syndrome is a heterogeneous group of renal disorders. While certain biochemical features in amniotic fluid might heighten suspicion, final diagnosis can only be made in the postnatal setting. In the setting of unexplained severe polyhydramnios, clinicians should continue to entertain the diagnosis of antenatal Bartter Syndrome and maintain neonatal surveillance, even if amniotic fluid markers do not support the diagnosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12891/ceog2143.2016

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Idiopathic polyhydramnios may be associated with macrosomia, and fetal growth restriction associated with polyhydramnios presents a high risk for an underlying fetal abnormality, including trisomy 13 or 18.

    “It is important to assess fetal growth because idiopathic polyhydramnios may be associated with macrosomia, and fetal growth restriction associated with polyhydramnios presents a high risk for an underlying fetal abnormality, including trisomy 13 or 18. 31,32”

    From SMFM Consult Series #46: Evaluation and management of polyhydramnios (2018) · cites this paper as [31]

    The Abstract and Discussion (page numbers unavailable) describe antenatal Bartter syndrome as a possible underlying condition when polyhydramnios occurs with fetal growth restriction. They do not support an association between idiopathic polyhydramnios and macrosomia, quantify a high risk of fetal abnormality, or identify trisomy 13 or 18 as causes in this setting. The Case Report mentions those trisomies only as conditions for which screening returned a low risk. (LLM, conf=0.83)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [1]1. Proesmans W., Massa G., Vandenberghe K., Van Assche A.: "Prena- tal diagnosis of Bartter syndrome". Lancet, 1987, 1, 394.
  2. [2]2. Ohlsson A., Sieck U., Cumming W., Akhtar M., Serenius F.: "A vari- ant of Bartter syndrome. Bartter's syndrome associated with hy- dramnios, prematurity, hypercalciuria and nephrocalcinosis". Acta Pediatr. Scand., 1984, 73, 868.

Cited by

Sorted by citations

Authors
Narayan, R., Peres, M., & Kesby, G.
Corresponding author
Narayan, R.
Venue
Clinical and Experimental Obstetrics & Gynecology
Publisher
IMR Press
Published
2016-06-10
Volume
43
Issue
3
Pages
453-454
ISSN
0390-6663 (ISSN-L)
OpenAlex
W2470573504
Cited by
3
References
13
Citations by year
2026: 1 · 2018: 1 · 2017: 1
FWCI
0.78
Type
journal article
Language
en
Open access
Locations
  • Clinical and Experimental Obstetrics & Gynecology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
antenatal Bartter syndrome, polyhydramnios, amniotic fluid biochemistry, renal tubular disorders, autosomal recessive inheritance, fetal growth restriction, neonatal surveillance, prenatal diagnosis
MeSH terms
Adult, Aldosterone, Amniotic Fluid, Bartter Syndrome, Bicarbonates, Female, Humans, Polyhydramnios, Infant, Newborn, Pregnancy, Prenatal Diagnosis, Sodium Chloride, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review